Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Radiat Oncol Biol Phys ; 82(5): 1674-9, 2012 Apr 01.
Article in English | MEDLINE | ID: mdl-21658856

ABSTRACT

PURPOSE: To construct a maximally predictive model of the risk of severe acute esophagitis (AE) for patients who receive definitive radiation therapy (RT) for non-small-cell lung cancer. METHODS AND MATERIALS: The dataset includes Washington University and RTOG 93-11 clinical trial data (events/patients: 120/374, WUSTL = 101/237, RTOG9311 = 19/137). Statistical model building was performed based on dosimetric and clinical parameters (patient age, sex, weight loss, pretreatment chemotherapy, concurrent chemotherapy, fraction size). A wide range of dose-volume parameters were extracted from dearchived treatment plans, including Dx, Vx, MOHx (mean of hottest x% volume), MOCx (mean of coldest x% volume), and gEUD (generalized equivalent uniform dose) values. RESULTS: The most significant single parameters for predicting acute esophagitis (RTOG Grade 2 or greater) were MOH85, mean esophagus dose (MED), and V30. A superior-inferior weighted dose-center position was derived but not found to be significant. Fraction size was found to be significant on univariate logistic analysis (Spearman R = 0.421, p < 0.00001) but not multivariate logistic modeling. Cross-validation model building was used to determine that an optimal model size needed only two parameters (MOH85 and concurrent chemotherapy, robustly selected on bootstrap model-rebuilding). Mean esophagus dose (MED) is preferred instead of MOH85, as it gives nearly the same statistical performance and is easier to compute. AE risk is given as a logistic function of (0.0688 MED+1.50 ConChemo-3.13), where MED is in Gy and ConChemo is either 1 (yes) if concurrent chemotherapy was given, or 0 (no). This model correlates to the observed risk of AE with a Spearman coefficient of 0.629 (p < 0.000001). CONCLUSIONS: Multivariate statistical model building with cross-validation suggests that a two-variable logistic model based on mean dose and the use of concurrent chemotherapy robustly predicts acute esophagitis risk in combined-data WUSTL and RTOG 93-11 trial datasets.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Esophagitis/etiology , Esophagus/radiation effects , Lung Neoplasms/radiotherapy , Models, Biological , Radiation Injuries/complications , Adult , Age Factors , Aged , Aged, 80 and over , Analysis of Variance , Carcinoma, Non-Small-Cell Lung/drug therapy , Cohort Studies , Female , Humans , Lung Neoplasms/drug therapy , Male , Middle Aged , Radiotherapy Dosage , Risk , Sex Factors , Tumor Burden , Weight Loss
2.
Phys Med Biol ; 51(5): L11-2, 2006 Mar 07.
Article in English | MEDLINE | ID: mdl-16481675

ABSTRACT

The Advanced Technology QA Consortium (ATC) has identified a problem in the encoding of DICOM RT Dose objects when these objects are converted from Implicit-VR (Little-Endian) transfer syntax to an Explicit-VR transfer syntax. There exist data elements, which can be represented in Implicit-VR Little-Endian transfer syntax but that cannot be represented in Explicit-VR Little-Endian transfer syntax.


Subject(s)
Radiotherapy, Computer-Assisted , Software , Clinical Trials as Topic
SELECTION OF CITATIONS
SEARCH DETAIL